galactose has been researched along with ciprofloxacin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, ME; Kaunitz, J; Kiankarimi, M; Spyrou, E; Vu, BT; Yang, EC | 1 |
| Carlson-Banning, KM; Chou, A; Hamill, RJ; Liu, Z; Song, Y; Zechiedrich, L | 1 |
| Kaushik, D; Madan, J; Mishra, D; Sardana, S | 1 |
| Amison, R; Banner, KH; Coulthard, A; Grevot, A; Growcott, EJ; Hardaker, EL; Jones, P; Malt, L; Osborne, C; Poll, C; Saxena, V | 1 |
4 other study(ies) available for galactose and ciprofloxacin
| Article | Year |
|---|---|
Glycosylation of fluoroquinolones through direct and oxygenated polymethylene linkages as a sugar-mediated active transport system for antimicrobials.
Topics: Anti-Infective Agents; Biological Transport, Active; Ciprofloxacin; Galactose; Glucose; Glycosylation; Half-Life; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Piperazines | 1999 |
Toward repurposing ciclopirox as an antibiotic against drug-resistant Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Biosynthetic Pathways; Ciclopirox; Ciprofloxacin; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Proteins; Galactose; Humans; Hydrogen Peroxide; Iron; Klebsiella pneumoniae; Lipopolysaccharides; Microbial Sensitivity Tests; Microbial Viability; Mutation; Phenotype; Pyridones | 2013 |
Effect of ciprofloxacin and chloramphenicol on humoral immune response elicited by bovine albumin encapsulated in niosomes.
Topics: Animals; Antibody Formation; Chloramphenicol; Ciprofloxacin; Drug Carriers; Hexoses; Immunoglobulin G; Liposomes; Male; Particle Size; Rats; Rats, Wistar; Serum Albumin, Bovine | 2007 |
Characterisation of a refined rat model of respiratory infection with Pseudomonas aeruginosa and the effect of ciprofloxacin.
Topics: Acute Disease; Agar; Animals; Anti-Infective Agents; Bacterial Load; Bronchoalveolar Lavage Fluid; Ciprofloxacin; Disease Models, Animal; Hexoses; Leukocyte Count; Male; Microspheres; Neutrophils; Particle Size; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections; Time Factors; Treatment Outcome | 2011 |